| Literature DB >> 28761061 |
Frank Po-Yen Lin1,2, Adrian Pokorny3, Christina Teng4, Richard J Epstein3,5.
Abstract
Vast amounts of clinically relevant text-based variables lie undiscovered and unexploited in electronic medical records (EMR). To exploit this untapped resource, and thus facilitate the discovery of informative covariates from unstructured clinical narratives, we have built a novel computational pipeline termed Text-based Exploratory Pattern Analyser for Prognosticator and Associator discovery (TEPAPA). This pipeline combines semantic-free natural language processing (NLP), regular expression induction, and statistical association testing to identify conserved text patterns associated with outcome variables of clinical interest. When we applied TEPAPA to a cohort of head and neck squamous cell carcinoma patients, plausible concepts known to be correlated with human papilloma virus (HPV) status were identified from the EMR text, including site of primary disease, tumour stage, pathologic characteristics, and treatment modalities. Similarly, correlates of other variables (including gender, nodal status, recurrent disease, smoking and alcohol status) were also reliably recovered. Using highly-associated patterns as covariates, a patient's HPV status was classifiable using a bootstrap analysis with a mean area under the ROC curve of 0.861, suggesting its predictive utility in supporting EMR-based phenotyping tasks. These data support using this integrative approach to efficiently identify disease-associated factors from unstructured EMR narratives, and thus to efficiently generate testable hypotheses.Entities:
Mesh:
Year: 2017 PMID: 28761061 PMCID: PMC5537364 DOI: 10.1038/s41598-017-07111-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The TEPAPA discovery pipeline. Abbreviations: EMR: electronic medical record.
Figure 2Illustrated methods of annotation, sub-sequence search, and regular expression induction. EMR narratives are tokenized, annotated, and transformed into text fragments (n-gram) prior to association testing. Syntactically similar n-grams are then (optionally) grouped into regular expressions with the aim to aggregate conceptually similar features improve overall recall.
The characteristics of HNSCC cohort by HPV/P16 status.
| Characteristic | Value | HPV/P16 status | P | |||
|---|---|---|---|---|---|---|
| Positive (n = 50) | Negative (n = 32) | |||||
| N | (%) | N | (%) | |||
|
| ||||||
| Age at diagnosis | Mean (years) | 61.5 | (95%CI: 58.9–64.2) | 65.5 | (95%CI: 60.9–70) | 0.14 |
| Gender | Male | 44 | (88) | 25 | (78) | 0.38 |
| Female | 6 | (12) | 7 | (22) | ||
|
| ||||||
| Diagnosis | Squamous cell carcinoma | 49 | (98) | 30 | (94) | 0.28 |
| Other tumour types | 1 | (2) | 2 | (6) | ||
| Laterality | Right | 20 | (61) | 4 | (40) | 0.37 |
| Left | 12 | (36) | 6 | (60) | ||
|
| 17 | 22 | ||||
| Site of origin | Oropharynx | 42 | (89) | 14 | (48) | <0.01 |
| Skin | 2 | (4) | 3 | (10) | ||
| Larynx | 0 | (0) | 9 | (31) | ||
| Lip | 1 | (2) | 2 | (7) | ||
| Nasal cavity | 1 | (2) | 0 | (0) | ||
| Nasopharynx | 1 | (2) | 0 | (0) | ||
| Salivary gland | 0 | (0) | 1 | (3) | ||
|
| 3 | 3 | ||||
| Recurrent disease | Yes | 20 | (43) | 14 | (45) | 1 |
| No | 26 | (57) | 17 | (55) | ||
|
| 4 | 1 | ||||
|
| ||||||
| T category | T1 | 11 | (23) | 7 | (23) | 0.52 |
| T2 | 14 | (29) | 5 | (16) | ||
| T3 | 14 | (29) | 10 | (32) | ||
| T4 | 3 | (6) | 5 | (16) | ||
| Tx | 6 | (12) | 4 | (13) | ||
|
| 2 | 1 | ||||
| N category | N0 | 10 | (21) | 11 | (35) | 0.35 |
| N1 | 9 | (19) | 6 | (19) | ||
| N2, nos | 3 | (6) | 1 | (3) | ||
| N2a | 7 | (15) | 1 | (3) | ||
| N2b | 11 | (23) | 7 | (23) | ||
| N2c | 7 | (15) | 2 | (6) | ||
| N3 | 0 | (0) | 1 | (3) | ||
| Nx | 1 | (2) | 2 | (6) | ||
|
| 2 | 1 | ||||
| M category | M0 | 43 | (90) | 28 | (90) | 0.39 |
| M1 | 0 | (0) | 1 | (3) | ||
| Mx | 5 | (10) | 2 | (6) | ||
|
| 2 | 1 | ||||
| TNM Stage (7th edition) | I | 2 | (4) | 5 | (17) | 0.17 |
| II | 2 | (4) | 2 | (7) | ||
| III | 13 | (27) | 7 | (23) | ||
| IV | 31 | (65) | 16 | (53) | ||
|
| 2 | 2 | ||||
|
| ||||||
| Ever smoked | Yes | 22 | (56) | 20 | (74) | 0.23 |
| No | 17 | (44) | 7 | (26) | ||
|
| 11 | 5 | ||||
| Smoking history | Median (pack-years) | 0 | (IQR: 0–27.5) | 25 | (IQR: 0–50) | 0.02 |
|
| 19 | 8 | ||||
| Current smoker | Yes | 11 | (28) | 10 | (37) | 0.625 |
| No | 28 | (72) | 17 | (63) | ||
|
| 11 | 5 | ||||
| Current amount | Median | 0 | (IQR: 0–0) | 10 | (IQR: 0–22.5) | 0.17 |
|
| 28 | 17 | ||||
| Last smoked | Median (years ago) | 1.12 | (IQR: 0.812–3.19) | 21 | (IQR: 18.5–24) | 0.02 |
|
| 50 | 26 | ||||
|
| ||||||
| Ever consumed | Yes | 27 | (82) | 21 | (84) | 1 |
| No | 6 | (18) | 4 | (16) | ||
|
| 17 | 7 | ||||
| Current drinker | Yes | 23 | (70) | 18 | (72) | 1 |
| No | 10 | (30) | 7 | (28) | ||
|
| 17 | 7 | ||||
| Current amount | Median (grams/day) | 60 | (IQR: 20–80) | 40 | (IQR: 20–80) | 0.70 |
|
| 23 | 11 | ||||
NB: IQR: Inter-quartile range; (a) Fisher’s exact test was used for hypothesis testing on categorical and binary data. Shapiro-Wilk test was used to determine the normality for numeric data. One-way Analysis of Variance (ANOVA) and Kruskal-Wallis tests were used to determine the difference between means (normally-distributed) and median (non-normally distributed) data respectively. (b) Significant between-group difference (p < 0.05) on the number of missing values (c) Statistically significant at α = 0.01.
Figure 3Flowchart of data analysis of the validation dataset.
Figure 4Volcano plot showing the ranking text features associated with HPV status discovered from the HNSCC MDT reports. Note: Labels of patterns with p < 0.002 are shown in this plot. Legend: ◆: regular expression. ∙: n-gram text fragments. The pattern of regular expression “(A|B)” indicates either A or B would match the string, and “?” indicates an optional element. The size of diamond or circle is proportional to total number of cases mentioning the text patterns in the EMR.
Informative features associated with HNSCC by HPV status as discovered by TEPAPA.
| Log (OR) | P | N | Text feature | Type | EMR Source | Interpretation | Crossref. |
|---|---|---|---|---|---|---|---|
|
| |||||||
| 3.50 | 3.0 × 10−6 | 25 | “HPV (studies|genotypes|status):? P16 immunohistochemistry:? Positive” | R | Pathology | HPV status (Self-referent) | (S3c.1) |
| 3.89 | 6.2 × 10−6 | 20 | “HPV (positive|genotypes: Positive|associated squamous cell carcinoma|related).” | R | Pathology | HPV status (Self-referent) | (S3c.2) |
| 3.29 | 2.0 × 10−5 | 23 | “No FDG avid? pulmonary (nodules|nodule) or pleural” | R | PET | (Lack of) metastasis to the lung | (S4c.1) |
| 3.14 | 5.6 × 10−5 | 21 | “HPV related” | N | Pathology | HPV status (Self-referent) | (S3b.6) |
| 2.06 | 0.00094 | 24 | “irradiation (and|with) (or without|concurrent) chemotherapy” | R | MDT | Management | (S2c.7) |
| 2.76 | 0.0093 | 9 | “oropharyngectomy:” | N | Pathology | Management, site of primary tumor | (S3a.22) |
| 3.23 | 0.0011 | 13 | “SCC of the right (tonsil|base of tongue|glossotonsillar sulcus) -” | R | MDT | Site of primary tumor | (S2d.4) |
| 2.68 | 0.0015 | 16 | “SCC of the (right|left)? base of tongue” | R | MDT | Site of primary tumor | (S2d.5) |
| 3.02 | 0.0023 | 11 | “M0” | N | MDT | Stage | (S2a.3) |
| 2.89 | 0.0047 | 10 | “non-keratinising” | N | Pathology | Pathology feature | (S3a.16) |
| 2.77 | 0.0092 | 9 | “p16? positive,? HPV? positive” | R | MDT | HPV status (Self-referent) | (S2c.17) |
|
| |||||||
| −3.54 | 0.00035 | 8 | “for decalcification” | N | Pathology | Pathology feature | (S3e.2) |
| −2.91 | 0.00089 | 10 | “a (locally|locoregionally)? (p16 negative|advanced) SCC” | R | MDT | HPV status and pathology feature | (S2h.3) |
| −3.17 | 0.0031 | 6 | “SCC of the supraglottic? (lower lip|larynx).” | R | MDT | Site of primary tumor | (S2g.7) |
| −2.96 | 0.0086 | 5 | “likely to? require adjuvant radiation therapy” | R | MDT | Management | (S2g.10) |
| −3.35 | 0.0011 | 7 | supportive care | N | MDT | Management | (S2f.3) |
| −2.59 | 0.0058 | 8 | “differentiated, keratinising squamous cell carcinoma” | N | Pathology | Pathology feature | (S3e.23) |
| −2.59 | 0.0058 | 8 | “well differentiated” | N | Pathology | Pathology feature | (S3e.26) |
Note: The type field indicates the type of text features (N: n-gram fragments or R: regular expression). N indicates number of documents containing the text features. Abbreviations: Log (OR): Log odds ratio. MDT: Multidisciplinary team meeting.
Literature-based comparison of features associated with HNSCC by HPV status.
| Variables | HPV status | Examples of highly-ranked, informative features | Reference | |
|---|---|---|---|---|
| HPV-related | HPV-unrelated | Log(OR), P-value (Crossref.) | ||
|
| ||||
| Age | Younger | Older | ( |
|
| Married | Associated | NS | ( |
|
|
| ||||
| Cigarette and alcohol exposure | Associated | Strongly associated | “ |
|
| Marijuana use | Associated | Associated | ( |
|
| Poor oral hygiene (incl. tooth loss) | Not associated | Associated | “ |
|
|
| ||||
| Oral sex partners | Associated | NS | ( |
|
| Number of lifetime sexual partners | Associated | NS | ( |
|
|
| ||||
| Cardiovascular | Risk factors (e.g. Hypertension) | Macrovascular arthrosclerotic disease | “ |
|
| Primary tumor site | Oropharynx | Non-oropharynx | “ |
|
|
| ||||
| T stage | Early T-stage | “ |
| |
| Nodal status | Multilevel, “High N-stage” Cystic nodes |
| ||
|
| ||||
| Grade | Moderately to poorly differentiated | Moderately differentiated | “ |
|
| Keratinisation | Absent | Present |
| |
| Other features | Basaloid morphology | Epithelial dysplasia |
| |
|
| ||||
| Locally advanced disease (T3/4 or N2/3) | Surgery + adjuvant radiotherapy +/− concurrent chemotherapy | “ |
| |
|
| ||||
| Overall survival | Better prognosis | Poorer prognosis | ( |
|
Abbreviations: NS: Not significant. Log(OR): Log odds ratio; Note: *Refers to part of “consumed (greater|less) than”, which was a phrase used to describe “ever-consumption of alcohol”. †The index concept was revealed only through “overfitting” the concept to a regular expression pattern flanked by two tokens. See main text for detailed discussions.
Predictive performance by varying methods annotation type, threshold selection, and machine learning methods.
| Pipeline variations | Corpus type | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| MDT meeting reports (N = 77) | Oncology letters (N = 14) | Pathology reports (N = 75) | FDG-PET/CT reports (N = 74) | All inclusive (N = 82) | ||||||
| Est. | P | Est. | P | Est. | P | Est. | P | Est. | P | |
| Mean (Intercept) | 0.634 | 0.559 | 0.835 | 0.759 | 0.861 | |||||
| Annotation method | ||||||||||
| None | (Ref.) | |||||||||
| POSTAG | 0.006 | 0.13 | 0.031 | <0.001 | −0.043 | <0.001 | −0.062 | <0.001 | NA | |
| STEM | 0.010 | 0.009 | 0.011 | 0.05 | 0.005 | 0.08 | 0.017 | <0.001 | 0.013 | 0.059 |
| SPARSE | −0.017 | <0.001 | 0.056 | <0.001 | 0.004 | 0.17 | −0.005 | 0.32 | NA | |
| UMLS | 0.013 | <0.001 | 0.030 | <0.001 | 0.004 | 0.17 | −0.190 | <0.001 | 0.014 | <0.001 |
| Post-processing | ||||||||||
| None | (Ref.) | |||||||||
| REGEXI | −0.003 | 0.17 | 0.003 | 0.44 | −0.003 | 0.09 | −0.002 | 0.50 | 0.007 | 0.018 |
| Machine learning algorithm | ||||||||||
| ADTree | (Ref.) | |||||||||
| Logistic regression | −0.0002 | 0.94 | 0.015 | <0.001 | −0.007 | 0.006 | −0.003 | 0.38 | −0.017 | <0.001 |
| Naive Bayes | 0.005 | 0.10 | 0.018 | <0.001 | 0.018 | <0.001 | 0.003 | 0.38 | 0.006 | 0.126 |
| Threshold selection | ||||||||||
| Optimal threshold | (Ref.) | |||||||||
| − | −0.022 | <0.001 | −0.040 | <0.001 | −0.013 | <0.001 | −0.011 | <0.001 | 0.003 | 0.15 |
| | 0.40 | 0.65 | 0.66 | 0.85 | 0.72 | |||||
NB: Abbreviations: ADTree: Alternating decision tree (10-boosting iterations); FDG-PET/CT:18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography; MDT: multidisciplinary team; POSTAG: Part-of-speech tagging with word lemmatization; REGEXI: regular expression induction algorithm; SPARSE: syntactic parsing; STEM: token-level annotation by word stemming using Snowball algorithm; UMLS: sequence-level annotation using Meta-thesaurus from the United Medical Language System (UMLS) version 2016 AA.
Figure 5Scenarios, examples, and potential sources of misdiscovery.